Hikma reiterates guidance despite Iran war hitting costs
23rd Apr 2026 08:17
(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance on Thursday, despite a rise in costs following the outbreak of war in the Middle East.
Read moreHikma names chair chief executive
26th Feb 2026 07:01
(Sharecast News) - Shares in Hikma Pharmaceuticals tumbled on Thursday, after the generics drugmaker withdrew its medium-term guidance and adopted a cautious outlook for the current year.
Read moreBrookfield not planning to make an offer for Hikma Pharmaceuticals
4th Feb 2026 17:43
(Sharecast News) - Brookfield confirmed on Wednesday that it does not plan on making an offer for Hikma Pharmaceuticals.
Read moreHikma chief executive steps down after two years in role
15th Dec 2025 07:01
(Sharecast News) - The chief executive of Hikma Pharmaceuticals has stepped down, it was announced on Monday, just over a month after the blue chip warned on profits.
Read moreBroker tips: Sabre Insurance, Hikma, Paragon Banking
7th Nov 2025 11:39
(Sharecast News) - RBC Capital Markets downgraded Sabre Insurance on Friday to 'sector perform' from 'outperform' and cut the price target to 135p from 170p as it said it was "waiting for delivery".
Read moreBerenberg cuts Hikma price target after update, maintains 'buy'
7th Nov 2025 09:50
(Sharecast News) - Berenberg cut its price target on Hikma Pharmaceuticals on Friday to 2,300p from 2,510p following the company's trading update a day earlier, in which it downgraded medium-term guidance for the injectables unit.
Read moreHikma trims medium-term injectables outlook, narrows profit guidance
6th Nov 2025 07:48
(Sharecast News) - Drugmaker Hikma Pharmaceuticals lowered its medium-term margin expectations for its injectables division on Thursday, as part of its third-quarter trading update.
Read moreDirector dealings: Hikma vice chair invests, Kier executives offload shares
17th Sep 2025 14:23
(Sharecast News) - Hikma Pharmaceuticals and Kier Group both reported director share dealings on Wednesday.
Read moreDirector dealings: Hikma Pharmaceuticals director raises stake
22nd Aug 2025 15:32
(Sharecast News) - Hikma Pharmaceuticals revealed on Friday that non-executive director Laura Balan had acquired 3,500 ordinary shares in the FTSE 100-listed drugmaker.
Read moreHikma on track to meet FY expectations despite H1 operating profit drop
7th Aug 2025 07:30
(Sharecast News) - Drugmaker Hikma Pharmaceuticals said on Thursday that it was on track to meet FY expectations, with solid top-line growth and strong demand across its portfolio helping offset margin pressures and a drop in operating profits.
Read moreRBC Capital ups price target on Hikma
20th May 2025 13:14
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.
Read moreBroker tips: Kingfisher, Accesso, Hikma
20th May 2025 07:34
(Sharecast News) - Barclays downgraded its stance on B&Q and Castorama owner Kingfisher on Tuesday to 'underweight' from 'equalweight' as it said the more than 25% year-to-date total shareholder return was "overly generous".
Read moreHikma surges as investors welcome medium-term guidance
15th May 2025 12:32
(Sharecast News) - Shares in Hikma Pharmaceuticals surged on Thursday as investors welcomed new medium-term guidance from the company.
Read moreLondon close: Burberry surges on mixed day for stocks
14th May 2025 15:02
(Sharecast News) - London stocks ended Wednesday's session narrowly mixed, as investors weighed a stream of corporate updates.
Read moreLondon close: Stocks rally on US-China tariff deal
12th May 2025 16:30
(Sharecast News) - London stocks ended higher on Monday as investors welcomed news of a temporary trade agreement between the United States and China that will see a rollback of some tariffs.
Read more